EBOS Group Ltd
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products.
The business
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Small Caps Research
No research on EBOS Group Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise EBO based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Sigma Healthcare beats EBOS to $3b supply contract with Chemist Warehouse
Independent pharmacy network owner Sigma Healthcare (ASX: SIG) has signed a five-year deal to supply Pharmaceutical Benefits Scheme (PBS) medicines and fast-moving consumer goods (FMCG) to retail giant Chemist Warehouse, starting next month. The deal replaces a current supply contract between Chemist Warehouse and Sigma rival EBOS Group (ASX: EBO), which will not be renewed once […]
Get bigger or pay money to shareholders – the choice facing companies
It has been a great time to be a shareholder with Australian companies increasingly stuffed with cash which they will now be looking to put to use. Those shareholders may selfishly hope that a lot of that cash will be heading in their direction – either in the form of bumper dividends or share buybacks […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.